Top Markets
Coin of the day
Arovella Therapeutics Limited Arovella Therapeutics Limited

Arovella Therapeutics Limited

ALA
Classificação em ações #24896
Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated... Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated to developing therapeutic solutions for oncology and central nervous system afflictions, operating both domestically and internationally. Its pipeline features several key assets, including ZolpiMist, an oral spray formulation of zolpidem tartrate for the treatment of short-term insomnia, commercially known by brands such as Ambien or Stilnox. The company is also advancing an invariant natural killer T (iNKT) cell therapy platform specifically designed to target blood cancers. Furthermore, Arovella employs OroMist, an oro-mucosal technology enabling the delivery of various drug classes through absorption in the oral cavity via the cheeks, gums, tongue, or mouth floor, and is developing Anagrelide for cancer treatment. Beyond these, the company is engaged in creating oral sprays to address conditions like migraine headaches, motion sickness, and drug-resistant epilepsy. Arovella maintains a research collaboration agreement with Imperial College London. Established in 1999 and based in Osborne Park, Australia, the company was formerly known as Suda Pharmaceuticals Ltd before rebranding to Arovella Therapeutics Limited in October 2021.
Preço da ação
$0.04584351
Valor de mercado
$55.42M
Variação (1 dia)
1.56%
Variação (1 ano)
-16.04%
País
AU
Negociar Arovella Therapeutics Limited (ALA)

Categoria

Histórico de preços das ações de Arovella Therapeutics Limited (ALA)
Preço de fecho mais alto: $0.04 em 2026-08-01

Preço de fecho mais baixo: $1.48 em 2002-01-01
Histórico de preços das ações da Arovella Therapeutics Limited de 2002 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 8.84%
2025 -52.69%
2024 61.67%
2023 305.30%
2022 -35.55%
2021 -8.52%
2020 -23.02%
2019 -54.20%
2018 -63.30%
2017 -14.45%
2016 -33.47%
2015 -53.40%
2014 -26.75%
2013 93.13%
2012 59.05%
2011 -63.96%
2010 4.61%
2009 -5.73%
2008 -54.25%
2007 47.42%
2006 0.76%
2005 -54.49%
2004 -35.11%
2003 206.90%
2002 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.57 8.46%
CH
$130.43 397.46%
US